CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943134940
- Phone
- 4154825300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale SVP, COO & CFO sold 24,149 shares at an average $13.10 ($316,391)
- 4 Open-market sale Chief R&D Officer sold 20,869 shares at $13.16 ($274,636)
- 4 Open-market sale SVP & General Counsel sold 6,564 shares at $13.16 ($86,382)
- 4 Open-market sale SVP & Chief Accounting Officer sold 6,741 shares at $13.16 ($88,712)
- 4 Open-market sale President & CEO sold 42,773 shares at $13.16 ($562,893)
- 4 Open-market sale SVP & Chief Commercial Officer sold 6,061 shares at $13.16 ($79,763)
- 4 Grant or award SVP, COO & CFO acquired 40,150 shares (grant or award)
- 4 Grant or award Director acquired 18,360 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Option exercise Director acquired 12,500 shares (option exercise)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- UPLOAD Other SEC-generated Letter
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 20 of 100 · 1,982 filings